Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 2,000 Shares of Stock
Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) Director Matthew Shair sold 2,000 shares of the firm’s stock in a transaction on Monday, June 24th. The shares were sold at an average price of $80.22, for a total transaction of $160,440.00. Following the completion of the transaction, the director now directly owns 232,522 shares of the […]
More Stories
Analysts Set Outset Medical, Inc. (NASDAQ:OM) Price Target at $4.64
Shares of Outset Medical, Inc. (NASDAQ:OM – Get Free Report) have been given an average recommendation of “Hold” by the...
Columbia Banking System, Inc. (NASDAQ:COLB) Receives $25.42 Average Target Price from Brokerages
Shares of Columbia Banking System, Inc. (NASDAQ:COLB – Get Free Report) have earned an average rating of “Hold” from the...
Renasant Co. (NASDAQ:RNST) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Renasant Co. (NASDAQ:RNST – Get Free Report) have been assigned an average rating of “Moderate Buy” from the...
Brokerages Set EnLink Midstream, LLC (NYSE:ENLC) Target Price at $15.33
EnLink Midstream, LLC (NYSE:ENLC – Get Free Report) has been given an average rating of “Hold” by the ten ratings...
Factory Orders Decline in August as Manufacturing Woes Deepen
By Tom Ozimek Factory orders unexpectedly fell in August, stoking concerns about the deepening downturn in the U.S. manufacturing sector....
Citigroup Increases Medtronic (NYSE:MDT) Price Target to $92.00
Medtronic (NYSE:MDT – Free Report) had its target price increased by Citigroup from $85.00 to $92.00 in a research note...